filovirus
caus
agent
sever
hemorrhag
fever
high
mortal
rate
human
envelop
singlestrand
negativesens
rna
virus
belong
two
genera
ebolaviru
marburgviru
least
five
ebolaviru
speci
singl
marburgviru
speci
filoviru
outbreak
sporad
render
develop
evalu
therapeut
vaccin
efficaci
human
trial
problemat
virul
pathogen
unit
state
food
drug
administr
fda
establish
guidelin
use
anim
model
surrog
human
efficaci
purpos
licensur
wellcharacter
low
passag
viru
prepar
critic
develop
evalu
medic
countermeasur
potenti
human
pathogen
reason
standard
lot
filovirus
requir
reproduc
highli
character
monitor
time
chang
properti
could
advers
affect
use
challeng
stock
therapeut
vaccin
studi
materi
produc
must
highest
qualiti
prefer
highest
infecti
concentr
titer
lowest
genom
equival
viral
genet
materi
infecti
viru
lowest
particl
infecti
viru
ratio
achiev
low
ratio
thought
repres
intact
viru
fewer
number
noninfecti
defect
interf
particl
one
key
success
accur
viru
quantif
commonli
use
method
filoviru
quantif
includ
plaqu
assay
transmiss
electron
microscopi
tem
gold
standard
quantifi
infecti
virus
plaqu
assay
provid
titer
base
virusinfect
cell
produc
plaqu
theori
plaqu
aris
singl
infecti
virion
result
provid
concentr
infecti
viru
particl
term
plaqueform
unit
pfuml
plaqu
assay
depend
live
cell
labor
intens
filovirus
requir
day
cultur
requir
highlevel
biocontain
biosafeti
gener
consist
reproduc
viral
titer
use
plaqu
assay
depend
number
key
paramet
cell
type
cell
confluenc
inoculum
volum
agaros
concentr
primari
secondari
overlay
cell
stain
reagent
concentr
well
day
cell
stain
plaqu
count
tissu
cultur
infecti
dose
assay
also
use
quantit
infecti
viru
commonli
use
filoviru
commun
tem
use
mani
year
determin
number
viru
particl
establish
shape
size
imag
particl
grid
techniqu
measur
infect
viabil
viru
particl
result
express
viru
particl
per
ml
vpml
tem
expens
sampl
prepar
highlevel
contain
challeng
tediou
requir
skill
technician
prepar
stain
grid
take
minimum
h
filoviru
particl
size
fairli
well
understood
length
vari
nm
diamet
nm
variou
configur
note
includ
filament
circular
shape
form
count
requir
microscopist
take
upward
h
count
singl
grid
quantit
revers
transcriptionpolymeras
chain
reaction
qrtpcr
rel
new
techniqu
enumer
genet
materi
compar
individu
sampl
standard
rna
curv
result
express
genom
equival
per
ml
geml
genom
sequenc
filovirus
similar
differ
speci
distinguish
use
primer
probe
uniqu
sequenc
strainspecif
quantit
realtim
rtpcr
assay
develop
use
laboratori
ebov
primer
target
glycoprotein
sudv
primer
target
nucleoprotein
marv
primer
target
matrix
protein
inactiv
addit
trizol
ls
sampl
subsequ
procedur
complet
outsid
biocontain
viru
counter
vc
virocyt
boulder
co
usa
instrument
reengin
nonsort
analyt
flow
cytomet
develop
specif
directli
quantifi
viru
particl
solut
independ
viru
speci
singl
univers
stain
step
use
proprietari
stain
combin
two
fluoresc
dye
one
specif
envelop
protein
specif
nucleic
acid
dna
rna
doubl
strand
singl
strand
viru
particl
contain
envelop
protein
nucleic
acid
stain
dye
stain
protein
larger
nm
genom
enumer
separ
stain
viru
pass
laser
vc
simultan
detect
fluoresc
signatur
count
intact
viru
particl
unlik
tradit
flow
cytometri
use
forward
scatter
trigger
base
size
criterion
vc
use
fluoresc
trigger
regist
event
minimum
fluor
per
viru
requir
accur
trigger
count
event
vc
threshold
valu
automat
determin
sampl
acquisit
data
analysi
use
discrimin
viru
event
background
signal
addit
order
elimin
possibl
calcul
particl
concentr
base
less
signific
number
event
vpml
minimum
number
simultan
event
must
least
sampl
contain
larg
amount
protein
elev
background
intens
purer
cleaner
sampl
matrix
easier
differenti
viru
background
accur
result
requir
background
valu
low
possibl
order
captur
mani
event
possibl
time
exclud
background
nois
test
new
unknown
sampl
matrix
seri
dilut
test
determin
best
dilut
use
subsequ
analys
previou
test
variou
dilut
filoviru
seed
stock
reveal
sampl
matrix
must
dilut
least
order
differenti
viru
particl
background
optim
dilut
matrix
determin
stain
process
vc
take
min
requir
wash
step
total
analysi
time
less
min
per
sampl
triplic
train
requir
oper
vc
minim
data
analysi
take
place
real
time
prepar
stain
sampl
use
vc
filovirus
must
occur
high
contain
use
instrument
also
pose
safeti
concern
must
address
appropri
due
design
unlik
potenti
risk
aerosol
gener
wast
end
mitig
risk
hepa
high
effici
particul
air
filter
ad
outlet
valv
wast
bottl
vc
place
oper
insid
standard
biosafeti
cabinet
larg
number
virus
count
instrument
includ
sever
influenza
strain
baculoviru
dengu
type
viru
human
coronaviru
herp
simplex
viru
type
rubella
viru
parainfluenza
viru
respiratori
syncyti
viru
like
filovirus
influenza
virus
present
filament
particl
easili
count
instrument
eas
sampl
prepar
speed
assay
less
subject
interrog
particl
make
techniqu
potenti
addit
tem
count
viru
particl
filoviru
stock
prepar
infecti
titer
genom
equival
particl
count
quantit
measur
must
accur
reproduc
robust
result
meaning
use
well
character
stock
pivot
efficaci
studi
requir
assay
standard
valid
evalu
viru
counter
instrument
suitabl
filoviru
particl
quantit
compar
vc
tem
use
number
differ
filoviru
stock
propag
vero
african
green
monkey
kidney
clone
cell
addit
investig
relationship
differ
method
use
quantit
filovirus
provid
valuabl
insight
result
deriv
variou
techniqu
filoviru
seed
stock
use
media
supernat
harvest
infect
vero
cell
visual
evid
cytopath
effect
least
cell
media
contain
fetal
bovin
serum
harvest
medium
clarifi
aliquot
singl
use
vial
immedi
store
tem
conduct
shortli
harvest
reveal
morpholog
typic
filovirus
viru
particl
present
numer
form
predomin
straight
filament
shape
toru
v
shape
also
present
length
rang
nm
excess
nm
particl
diamet
report
seed
stock
ebola
viru
ebov
kikwit
variant
dilut
begin
hank
balanc
salt
solut
buffer
four
serial
log
dilut
prepar
order
provid
sampl
lie
within
linear
rang
vc
four
addit
serial
dilut
prepar
dilut
total
nine
dilut
sampl
stock
use
prepar
dilut
sampl
initi
plaqu
assay
titer
pfuml
code
sampl
test
quantit
method
use
examin
reproduc
linear
correl
variou
method
previous
character
stock
ebov
kikwit
variant
sudan
viru
sudv
gulu
variant
marburg
viru
marv
angola
variant
analyz
compar
vc
tem
particl
concentr
sampl
gener
dilut
serial
seri
test
viral
plaqu
assay
use
confluent
sixwel
plate
vero
cell
describ
shurtleff
et
al
briefli
six
well
inocul
dilut
plate
rock
everi
min
minim
dri
monolay
h
incub
ml
semisolid
agaros
overlay
ad
well
plate
incub
seven
day
cell
stain
ml
secondari
overlay
includ
neutral
red
gibco
life
technolog
grand
island
ny
usa
plaqu
well
count
h
poststain
titer
sampl
calcul
well
countabl
plaqu
factor
dilut
final
concentr
seed
stock
establish
use
result
sampl
plaqu
count
sampl
test
triplic
ebovspecif
qrtpcr
assay
develop
valid
laboratori
briefli
synthet
viral
rna
repres
target
region
ebovkikwit
assay
dilut
rnase
free
water
use
gener
standard
curv
determin
ebovkikwit
variant
concentr
sampl
place
trizol
ls
life
technolog
carlsbad
ca
usa
remov
biocontain
rna
purifi
use
qiaamp
viral
rna
mini
kit
accord
manufactur
instruct
qiagen
inc
valencia
ca
usa
volum
pre
postextract
equival
control
synthet
rna
sampl
assay
triplic
abi
instrument
appli
life
technolog
extract
sampl
assay
undilut
synthet
rna
quantifi
genom
equival
per
reaction
gereact
run
serial
dilut
gereact
abi
softwar
use
synthet
rna
cross
threshold
ct
valu
calcul
slope
yintercept
valu
standard
curv
use
ct
valu
sampl
gereact
interpol
slope
yintercept
standard
curv
trizol
dilut
factor
use
calcul
geml
sampl
final
concentr
seed
stock
establish
use
sampl
result
fell
within
linear
rang
assay
factor
dilut
sampl
equal
mixtur
sampl
filovir
particl
dilut
nm
polystyren
bead
spi
suppli
west
chester
pa
usa
adsorb
charg
formvarcarbonco
nickel
grid
spi
suppli
fix
use
cacodylatebuff
glutaraldehyd
steril
exposur
vapor
osmium
tetroxid
remov
biocontain
three
grid
prepar
sampl
viral
particl
polystyren
bead
count
least
randomli
chosen
squar
grid
volum
calcul
divid
number
bead
count
known
concentr
per
ml
bead
solut
viral
stock
solut
ratio
vpml
determin
divid
count
particl
calcul
volum
sampl
vbead
countedbead
concentr
per
ml
viral
particl
per
mlviral
particl
countedv
final
viru
particl
concentr
seed
stock
establish
use
result
sampl
countabl
number
particl
three
grid
factor
dilut
sampl
vc
reagent
kit
virocyt
use
follow
manufacturerrecommend
procedur
instrument
perform
valid
prior
test
sampl
run
nonbiolog
posit
control
stain
bead
perform
valid
standard
use
instrument
perform
check
cleanli
control
verifi
flow
path
clean
briefli
sampl
stain
use
combo
dye
solut
incub
dark
room
temperatur
min
analyz
vc
sampl
test
triplic
intersampl
wash
cleanli
control
run
sampl
result
automat
analyz
instrument
softwar
report
vpml
neg
control
sampl
dilut
test
establish
sampl
quantif
limit
neg
control
sampl
clarifi
medium
collect
uninfect
vero
cell
prepar
parallel
ebov
prepar
vc
result
greater
valu
consid
statist
distinguish
neg
control
background
therefor
report
sampl
quantif
limit
determin
use
follow
equat
sampl
quantif
xneg
mean
valu
neg
control
sampl
standard
deviat
neg
control
sampl
valu
degre
freedom
confid
level
final
viru
particl
concentr
seed
stock
establish
use
sampl
whose
vpml
count
sampl
quantif
limit
within
linear
rang
instrument
factor
dilut
sampl
microsoft
excel
redmond
wa
usa
use
linearregress
analysi
graphpad
prism
softwar
lajolla
ca
usa
use
perform
pearson
correl
analysi
determin
correl
assay
correl
coeffici
r
pvalu
pvalu
consid
statist
signific
total
nine
dilut
sampl
gener
use
ebov
kikwit
variant
stock
sampl
code
test
use
variou
quantit
method
result
shown
figur
everi
sampl
quantifi
plaqu
assay
figur
number
plaqu
use
determin
sampl
titer
per
well
except
dilut
sampl
dilut
plaqu
per
well
use
nine
sampl
experiment
plaqu
assay
result
slope
experiment
titer
correl
well
theoret
valu
pearson
r
p
valu
use
sampl
whose
titer
establish
use
plaqu
count
concentr
stock
viru
determin
pfuml
differ
log
origin
titer
pfuml
coeffici
variat
cv
first
seven
sampl
rang
two
dilut
sampl
ebovspecif
qrtpcr
assay
linear
ge
synthet
rna
per
reaction
figur
standard
curv
use
determin
geml
slope
intercept
data
shown
lowest
copi
number
quantifi
qrtpcr
correspond
dilut
stock
viru
equival
pfuml
detect
result
dilut
fell
outsid
linear
rang
assay
cv
use
seven
sampl
whose
result
fell
within
linear
rang
assay
experiment
result
slope
experiment
titer
correl
well
theoret
valu
pearson
r
p
valu
geml
seed
stock
determin
differ
log
origin
geml
concentr
geml
cv
rang
sampl
fell
within
linear
rang
assay
three
grid
dilut
sampl
prepar
count
use
tem
particl
morpholog
includ
assess
viru
particl
detect
sampl
dilut
greater
equival
pfuml
result
tem
shown
figur
concentr
sampl
viru
particl
three
grid
count
yield
particl
concentr
two
three
grid
two
sampl
viru
particl
use
three
sampl
experiment
result
slope
experiment
titer
correl
theoret
valu
pearson
r
p
valu
use
concentr
sampl
particl
concentr
determin
vpml
stock
differ
log
origin
vpml
concentr
vpml
cv
replic
sampl
uninfect
vero
cell
cultur
media
use
determin
background
sampl
quantif
limit
vc
use
total
valu
determin
sampl
quantif
limit
instrument
vpml
data
shown
sampl
vpml
result
equal
valu
report
limit
detect
instrument
ie
instrument
qualif
limit
three
replic
dilut
sampl
test
vc
viru
particl
detect
sampl
dilut
greater
equival
pfuml
result
vc
shown
figur
use
five
sampl
concentr
linear
rang
instrument
vpml
valu
experiment
result
slope
experiment
titer
correl
well
theoret
valu
pearson
r
p
valu
particl
concentr
determin
vpml
stock
differ
log
origin
vpml
concentr
vpml
cv
rang
sampl
fell
within
linear
rang
instrument
similar
dilut
analys
done
number
filovirus
use
vc
stock
yield
linear
regress
fit
slope
valu
slope
confirm
strong
posit
correl
linear
relationship
vc
result
dilut
valu
data
shown
relationship
infecti
viru
genom
materi
viru
particl
measur
vc
tem
shown
figur
result
demonstr
linear
relationship
assay
valu
method
except
tem
slope
plaqu
assay
qrtpcr
vc
tem
present
figur
studi
demonstr
vc
qrtpcr
quantit
techniqu
correl
well
tradit
plaqu
assay
howev
tem
particl
count
figur
demonstr
vc
particl
count
techniqu
correl
ebovspecif
qrtpcr
tem
particl
count
correl
correl
two
viru
particl
quantit
method
use
tem
result
three
dilut
p
data
shown
summari
initi
quantit
assay
result
ebov
kikwit
variant
stock
describ
shown
tabl
prep
addit
quantit
assay
result
number
differ
filoviru
stock
also
shown
tabl
gener
particl
count
greater
plaqu
assay
lower
gener
qrtpcr
differ
two
particl
count
method
shown
viru
stock
rang
log
current
filoviru
quantit
method
includ
plaqu
assay
qrtpcr
tem
viru
quantitationspecif
assay
use
differ
laboratori
vari
depend
size
biocontain
space
user
prefer
specif
need
filoviru
plaqu
assay
gold
standard
assay
quantit
plaqu
assay
quantifi
infecti
viru
use
mani
year
filoviru
research
assay
biolog
natur
depend
live
cell
abil
infect
produc
plaqu
assay
measur
infecti
viru
ratio
infecti
viru
particl
plaqu
unknown
mani
step
contribut
accuraci
reproduc
result
standard
train
period
assess
ensur
result
alway
optim
repeat
compon
precis
defin
studi
cv
replic
plaqu
assay
cv
rang
dilut
sampl
exhibit
highest
valu
titer
establish
sampl
within
log
reproduc
express
studi
differ
titer
stock
concentr
determin
time
prepar
achiev
studi
good
log
differ
titer
origin
titer
quantit
rtpcr
measur
genet
materi
rna
specif
primer
probe
use
assay
qrtpcr
use
quantifi
mani
virus
includ
influenza
human
immunodefici
viru
dengu
due
amplif
nucleic
acid
assay
sensit
wide
linear
rang
facilit
quantit
design
primer
probe
requir
substanti
expertis
amplif
occur
genom
well
free
nucleic
acid
long
target
sequenc
present
sampl
assay
rel
quick
h
due
multipl
step
sensit
techniqu
prone
error
contamin
rel
expens
requir
virusspecif
set
primer
probe
reproduc
sourc
control
materi
skill
technician
minim
contamin
valid
lower
limit
quantit
ebovspecif
qrtpcr
shown
ge
per
reaction
ebov
stock
equival
pfuml
repeat
assay
excel
cv
geml
valu
within
log
sampl
fell
within
linear
rang
assay
reproduc
within
log
origin
concentr
viru
particl
count
tem
quantifi
number
virion
meet
specif
criteria
size
shape
consist
filovirus
filoviru
particl
size
fairli
well
establish
problemat
sinc
viru
pleomorph
vari
proport
long
filament
shape
form
circular
configur
although
nucleocapsid
particl
diamet
consist
within
among
speci
averag
particl
length
nm
vari
nm
depend
viru
cell
use
propag
particl
contain
nucleocapsid
diamet
roughli
nm
contain
nucleocapsid
nm
provid
guidanc
count
intact
potenti
infecti
particl
tem
faster
plaqu
assay
like
qrtpcr
take
hour
complet
virusspecif
reagent
requir
howev
rel
expens
laboratori
requir
expertis
instrument
tem
particl
count
although
current
method
choic
enumer
viru
particl
rel
high
limit
detect
vpml
contribut
inabl
quantit
viru
beyond
first
dilut
differ
method
sampl
prepar
lower
limit
detect
vpml
use
methodolog
requir
purif
sucros
densiti
gradient
concentr
highspe
pellet
follow
fixat
embed
resin
use
methodolog
would
alter
sampl
composit
provid
particl
count
found
stock
viru
tem
particl
count
also
highli
variabl
report
literatur
rel
error
high
standard
deviat
log
variabl
may
aris
grid
prepar
loss
specimen
andor
refer
bead
sampl
fixat
grid
wash
signific
challeng
precis
repeat
reproduc
tem
prefix
dri
fixat
artifact
uneven
sampl
distribut
clump
sampl
andor
refer
bead
background
caus
media
salt
protein
present
sampl
matrix
prepar
qualiti
grid
especi
challeng
biosafeti
environ
dexter
extrem
limit
count
subject
effect
reduc
standard
crosstrain
period
assess
studi
repeat
cv
assay
concentr
sampl
test
reproduc
within
log
origin
concentr
tem
particl
count
correl
three
quantit
assay
mainli
due
lack
sampl
could
compar
dilut
ebov
chosen
studi
design
provid
sampl
would
fall
within
vc
quantit
limit
sinc
assum
tem
lower
sensit
low
number
particl
count
per
grid
high
cv
note
concentr
sampl
indic
near
limit
detect
assay
pfuml
studi
tem
result
prove
problemat
aris
qualiti
prepar
grid
higher
sensit
vc
rapid
method
provid
realtim
result
multipl
sampl
less
h
cost
per
sampl
run
triplic
approxim
per
replic
train
use
care
instrument
minim
use
instrument
filovirus
requir
high
contain
pose
aerosol
hazard
must
care
mitig
onestep
assay
instrument
softwar
easi
use
requir
highli
train
individu
due
univers
stain
assay
use
wide
varieti
virus
vc
amen
quantifi
filoviru
particl
directli
sampl
high
level
protein
found
clinic
sampl
whole
blood
serum
plasma
stock
prepar
fetal
bovin
serum
concentr
greater
sampl
type
initi
dilut
requir
lower
background
level
analysi
matric
possibl
would
requir
purif
method
remov
exogen
protein
easili
conceptu
autom
count
homogen
spheric
virus
herp
simplex
baculoviru
dengu
vc
shown
reproduc
enumer
influenza
b
contain
filament
particl
virus
vc
result
shown
linear
relationship
correl
plaqu
assay
qrtpcr
tem
andor
tissu
cultur
infecti
dose
assay
abil
count
heterogen
particl
due
vc
trigger
two
simultan
fluoresc
event
signal
viru
particl
pass
laser
size
shape
target
convent
flow
cytometri
analysi
media
neg
control
requir
establish
sampl
quantit
limit
assay
matrix
vpml
ebov
stock
equival
pfuml
repeat
assay
similar
plaqu
assay
cv
rang
vpml
valu
within
log
sampl
fell
within
linear
rang
assay
reproduc
within
log
demonstr
linear
relationship
plaqu
assay
qrtpcr
vc
particl
count
higher
viru
concentr
test
work
describ
studi
suggest
tem
assay
would
also
linear
data
present
studi
show
vc
capabl
provid
rapid
filoviru
quantit
seed
stock
result
significantli
correl
plaqu
assay
r
p
qrtpcr
r
p
applic
vc
filoviru
stock
illustr
tabl
result
four
differ
ebov
kikwit
prep
well
singl
variant
sudv
marv
present
direct
correl
concentr
variou
viru
stock
note
particl
count
greater
plaqu
titer
lower
genom
equival
variabl
seen
possibl
due
time
amount
cell
lysi
prepar
harvest
multipl
infect
moi
use
produc
stock
known
affect
infecti
viru
titer
kikwit
prep
repres
similar
vero
passag
three
stock
prepar
moi
prep
repres
passag
two
stock
ebov
variant
prep
produc
moi
prep
like
sudv
gulu
marv
angola
variant
produc
moi
result
reveal
log
surplu
viral
genet
materi
produc
compar
number
viru
particl
measur
vc
addit
two
log
particl
infecti
viru
result
may
due
amount
cell
lysi
time
harvest
perhap
ineffici
filoviru
virion
packag
similar
pattern
note
filovirus
weidman
colleagu
compar
plaqu
assay
qrtpcr
focusform
assay
use
virusspecif
antibodi
varieti
hemorrhag
fever
virus
studi
demonstr
virus
exampl
lassa
yellow
fever
effici
replic
packag
infecti
virus
other
filovirus
rift
valley
fever
viru
shown
tabl
vc
tem
particl
count
within
one
log
also
within
normal
variabl
seen
tem
data
shown
tem
improv
institut
variabl
techniqu
improv
differ
decreas
vc
assay
simpl
conduct
train
minim
virusspecif
reagent
requir
due
use
instrument
analysi
quantif
nonsubject
requir
min
per
reaction
instrument
rel
small
place
insid
standard
biosafeti
cabinet
instal
oper
qualif
establish
assay
control
avail
verifi
instrument
function
claim
particl
count
substitut
techniqu
measur
infecti
viru
genom
materi
feel
use
vc
quantit
viru
particl
seed
stock
viabl
altern
challeng
less
sensit
tem
method
minimum
vc
provid
addit
tool
rapid
precis
reproduc
costeffect
quantif
filoviru
particl
stock
prepar
could
prove
use
monitor
variou
step
viru
propag
purif
